HIVE Blockchain Technologies (HIVE) had the highest return in 2017 by a small-cap US stock, returning 3,814.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
HIVE Blockchain Technologies (HIVE) | 2017 | 3,814.29% |
Gravity (GRVY) | 2017 | 801.72% |
Cronos (CRON) | 2017 | 592.83% |
Quantum Computing (QUBT) | 2017 | 566.67% |
AnaptysBio (ANAB) | 2017 | 529.5% |
Semler Scientific (SMLR) | 2017 | 429.8% |
Sangamo Therapeutics (SGMO) | 2017 | 429.03% |
Esperion Therapeutics (ESPR) | 2017 | 414.38% |
Dynavax Technologies (DVAX) | 2017 | 367.5% |
Global Industrial (GIC) | 2017 | 281.26% |
BioLife Solutions (BLFS) | 2017 | 270.37% |
Pulse Biosciences (PLSE) | 2017 | 263.08% |
Everi (EVRI) | 2017 | 249.07% |
Uniqure (QURE) | 2017 | 247.34% |
Canopy Growth (CGC) | 2017 | 243.77% |
Lendingtree (TREE) | 2017 | 230.86% |
P10 (PX) | 2017 | 225.97% |
Astrana Health (ASTH) | 2017 | 220% |
Sage Therapeutic (SAGE) | 2017 | 216.93% |
Axogen (AXGN) | 2017 | 210.99% |
Penguin Solutions (PENG) | 2017 | 206.36% |
Daqo New Energy Corp ADR (DQ) | 2017 | 202.03% |
SolarEdge Technologies (SEDG) | 2017 | 199.2% |
Lithium Americas (Argentina) (LAAC) | 2017 | 196.39% |
UroGen Pharma (URGN) | 2017 | 180.2% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
